Influenza Archives
How to trick a wily virus
Jul. 24, 2015—Vanderbilt investigators have discovered how human antibodies induced during testing of an experimental “bird flu” vaccine kill the virus.
VUMC updates faculty, staff immunization policy
Jul. 16, 2015—Members of Vanderbilt University Medical Center’s Medical Board recently approved updates to the VUMC Immunization Policy for Faculty and Staff.
VU lands $9 million NIH grant to design better flu vaccines
May. 15, 2015—Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.
Flu surveillance study tracks pediatric vaccination rates
Jan. 8, 2015—A study appearing in the January edition of Pediatrics, led by researchers at Vanderbilt University Medical Center, looks at how Nashville children ages 6 months through 5 years fared over 11 consecutive flu seasons concluding in 2010-11.
Flulapalooza is Oct. 1
Sep. 19, 2014—Less than 10 seconds – that’s as long as it takes to roll up your sleeve and be part of Wednesday's Flulapalooza, Vanderbilt University Medical Center’s mass flu vaccination event.
Flulapalooza vaccination event takes place Oct. 1
Aug. 21, 2014—Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that three years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period.
Enzyme holds the door for influenza
Aug. 20, 2014—Compounds developed at Vanderbilt University may offer a new way to block influenza infection.
High-dose flu vaccine more effective in elderly, Vanderbilt-led study shows
Aug. 13, 2014—High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.
Cutting-edge research to be showcased in May
May. 1, 2014—Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations to the Vanderbilt Biomedical Science Advisory Board, a group of...
Flu boosts pneumococcal colonization
Mar. 27, 2014—Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.
VU testing vaccine against new flu threat
Sep. 19, 2013—Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring.
Controversial info release aids VUMC bird flu research
Sep. 5, 2013—Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin.
